Provided herein are polymers of Formula (I), and pharmaceutically acceptable salts, co-crystals, tautomers, stereoisomers, and isotopically labeled derivatives thereof, compositions, and formulations thereof. The polymers described herein are biocompatible, non-toxic, water compatible, and operationally simple to formulate. Also provided are methods and kits involving the polymers described herein (e.g., methods of using polymers described herein for delivering agents (e.g., for therapeutic, diagnostic, prophylactic, imaging, ophthalmic, intraoperative, or cosmetic use) to a subject, cell, tissue, or biological sample, as part of materials (e.g., biodegradable materials, biocompatible materials, wound dressing (e.g., bandages), drug depots, coatings), or as scaffolds for tissue engineering. Provided are methods for synthesizing the polymers described herein, and polymers described herein synthesized by the synthetic methods described herein. ##STR00001##

Being used for drug modification, the multi-arm single molecular weight polyethylene glycol active derivative provided herein can effectively improve the solubility, stability, and immunogenicity of the drugs, improve the absorption of the drugs in vivo, prolong the half-life of the drugs, and increase bioavailability, enhance efficacy, and reduce toxic and side effects of the drugs. A gel formed from the multi-arm single molecular weight polyethylene glycol active derivative provided herein can be used for the preparation of controlled release drugs so as to prolong the action time of the drugs, thereby reducing the number of administrations and improving patient compliance.

The invention relates to block copolymer comprising i) A first block wherein at least 65 mol-% of the repeating units of the first block are repeating units of the formula (I)—[CH.sub.2—CH.sub.2—O]—, ii) A second block wherein at least 90 mol-% of the repeating units of the second block are repeating units of at least one of formulae (II) or (III), wherein the groups R.sup.1, R.sup.2, and R.sup.3 independent of each occurrence are selected from hydrocarbyl groups having 1 to 40 carbon atoms, which are optionally substituted by ether or hydroxyl groups, and wherein the groups R.sup.1 and R.sup.2 are optionally linked to each other such that a nitrogen heterocyclic structure is present, iii) A third block which is different from the first block and the second block and which is more hydrophobic than the first block.

##STR00001##

The present disclosure relates to enzymatic and redox responsive polymeric micelle, its method of production as well as its uses. Specifically, use of the enzymatic- and redox-responsive polymeric micelle for drug delivery.

This invention relates to end-modified branched block copolymers for soil treatment applications. The end-modified branched block copolymers contain an alkoxylated block copolymer modified with a hydrophobic end group such as an alkysuccinic acid ester, a fatty acid ester, or an ether. Soils treated with these copolymers exhibit improved soil water penetration properties with enhanced atmospheric moisture absorption and provide overall healthier turf and/or plants contained therein.

The present disclosure provides a pour point dispersant composition comprising an alkoxylated alkyl amine polyester. The pour point depressant composition may optionally be combined with a solvent and added to a hydrocarbon composition to improve the cold-flow properties of the hydrocarbon composition.

The present disclosure provides conjugates comprising a Factor VIII moiety covalently attached via an oxime-containing linkage to a water-soluble polymer, such as for example, a polyethylene glycol polymer. Methods for preparing and for administering such conjugates, are also provided, as are water-soluble polymer oxyamine reagents useful for preparing the subject conjugates, among other things.

Oxybate-PEG ester prodrugs are provided herein in which the polyethylene glycol is bound to oxybate via an ester linkage. These oxybate-PEG esters may be further bound to a cyclodextrin or an anion exchange resin, via an ester linkage between the oxybate and the cyclodextrin or via ionic bonding between oxybate the anion exchange resin. Compounds and compositions containing these compounds are useful in immediate release and modified release compositions for treating narcolepsy and other disorders.

A fluoropolyether group-containing silane compound represented by the following formula (I) wherein the symbols are as defined herein:

##STR00001##

The invention relates to ester-linked surface-modifying macromolecules and admixtures thereof as shown below by the representative compounds. The admixtures can be used in industrial and medical applications where enhanced surface properties are desirable (e.g., surface properties reducing or preventing biofouling, immobilization of biomolecules, or denaturation of certain biomolecules).

##STR00001##